Literature DB >> 27241369

In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.

Javier Fernández1, Kerryl E Greenwood-Quaintance2, Robin Patel3.   

Abstract

The in vitro activity of dalbavancin was tested against biofilms of 171 staphylococci associated with prosthetic joint infection. Dalbavancin minimum biofilm bactericidal concentration (MBBC) values were: MBBC50 for Staphylococcus aureus and Staphylococcus epidermidis, 1μg/mL; MBBC90 for S. aureus, 2μg/mL; MBBC90 for S. epidermidis, 4μg/mL.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dalbavancin; Prosthetic joint infection; Staphylococci

Mesh：

Substances：

Year:  2016        PMID： 27241369     DOI： 10.1016/j.diagmicrobio.2016.05.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  20 in total

Review 1.  New Innovations in the Treatment of PJI and Biofilms-Clinical and Preclinical Topics.

Authors:  Mariam Taha; Hesham Abdelbary; F Patrick Ross; Alberto V Carli
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

2.  Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections.

Authors:  Pier Giorgio Cojutti; Matteo Rinaldi; Eleonora Zamparini; Nicolò Rossi; Sara Tedeschi; Matteo Conti; Federico Pea; Pierluigi Viale
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

3.  In Vitro Study To Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution.

Authors:  Marta Rubia; Andrea Cordero; María Jesús Pérez-Granda; Emilia Cercenado; Cristina Pascual; Patricia Muñoz; María Guembe
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

4.  Evaluation of Non-Tissue Culture- versus Tissue Culture-Treated Microplates for Oritavancin Susceptibility Testing.

Authors:  Qun Yan; Melissa J Karau; Robin Patel
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

5.  Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.

Authors:  L Morata; J Cobo; M Fernández-Sampedro; P Guisado Vasco; E Ruano; J Lora-Tamayo; M Sánchez Somolinos; P González Ruano; A Rico Nieto; A Arnaiz; M Estébanez Muñoz; M E Jiménez-Mejías; A B Lozano Serrano; E Múñez; D Rodriguez-Pardo; R Argelich; A Arroyo; J M Barbero; F Cuadra; A Del Arco; M D Del Toro; L Guio; D Jimenez-Beatty; N Lois; O Martin; R M Martínez Alvarez; F J Martinez-Marcos; L Porras; M Ramírez; J Vergas García; A Soriano
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 6.  Phenazine Antibiotic-Inspired Discovery of Bacterial Biofilm-Eradicating Agents.

Authors:  Robert W Huigens; Yasmeen Abouelhassan; Hongfen Yang
Journal:  Chembiochem       Date:  2019-10-02       Impact factor: 3.164

Review 7.  Understanding Biofilms and Novel Approaches to the Diagnosis, Prevention, and Treatment of Medical Device-Associated Infections.

Authors:  Yu Mi Wi; Robin Patel
Journal:  Infect Dis Clin North Am       Date:  2018-09-18       Impact factor: 5.982

Review 8.  Challenges of antibiotic resistance biofilms and potential combating strategies: a review.

Authors:  Javairia Khan; Sumbal Mudassar Tarar; Iram Gul; Uzam Nawaz; Muhammad Arshad
Journal:  3 Biotech       Date:  2021-03-16       Impact factor: 2.406

Review 9.  Early recognition of methicillin-resistant Staphylococcus aureus surgical site infections using risk and protective factors identified by a group of Italian surgeons through Delphi method.

Authors:  G Sganga; C Tascini; E Sozio; S Colizza
Journal:  World J Emerg Surg       Date:  2017-06-12       Impact factor: 5.469

Review 10.  Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review.

Authors:  Luis Buzón-Martín; I Zollner-Schwetz; Selma Tobudic; Emilia Cercenado; Jaime Lora-Tamayo
Journal:  Antibiotics (Basel)       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.